Aquestive's Anaphylm, which is set for an imminent FDA filing, has blockbuster potential. See why I think AQST stock is a buy ...
Reports of anaphylaxis associated with the use of glatiramer acetate have prompted the Food and Drug Administration (FDA) to add a Boxed Warning to the prescribing information.
18h
Discover Magazine on MSNNew Therapy Offers Promising Solution to Childhood Peanut AllergiesWhat is oral immunotherapy? Learn how this new therapy could help children treat their peanut allergies, but how there is ...
20h
GB News on MSNProduct recall: Britons warned as popular kitchen staple may cause vomiting and nausea - 'do not eat it!'British shoppers have been warned that an urgent food recall is being extended, affecting anyone with a peanut allergy.
Australia is grappling with a surge in venomous red fire ant populations after heavy rains forced them above ground. These ...
A retired firefighter, Sen. Kelly Seyarto has advocated to be more involved in disaster management work. A new committee ...
OMLYCLO® (omalizumab-igec) is the first and only omalizumab biosimilar approved by the FDA Regulatory approval for interchangeability was supported by positive phase III data demonstrating comparable ...
FDA stated in written correspondence for a START pilot program meeting that it is open to considering skin FXN concentration as a reasonably ...
Studies show that eating two and a half servings of strawberries per day may reduce low-density lipoprotein concentrations ...
The potato plant looks pretty attractive, but the leaves and stems are not edible. They contain solanine, arsenic, and ...
ARS Pharmaceuticals, Inc.'s stock soared 25% on strong earnings. Learn about neffy's market potential, risks, and future ...
Cash Position & Operating Runway : As of December 31, 2024, ARS Pharma had cash, cash equivalents, and short-term investments of $314.0 million, with 97,954,172 shares of common stock outstanding. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results